Upper respiratory tract infections in the immunocompromised host. NLM AIDSLINE Important note: Information in this article was accurate in 1995. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Upper respiratory tract infections in the immunocompromised host.

Semin Respir Infect. 1995 Mar;10(1):37-50. Unique Identifier : AIDSLINE MED/95281871
Morrison VA; Pomeroy C; Minneapolis Veterans Affairs Medical Center, MN 55417, USA.

Abstract: Infections of the upper respiratory tract are a major source of morbidity and mortality in the immunocompromised host. The risks and types of infections are dictated by the specific immune defects present in the patient. Infections may involve virtually any of the structures in the upper respiratory tract, including the oral cavity, pharynx, larynx, trachea, ear, and sinuses. Infections may be complicated by abscess formation or invasion of critical central nervous system or neck space structures. Physicians must maintain a high index of clinical suspicion for upper respiratory tract infections, especially because they may present in an atypical fashion or be caused by unusual organisms in immunocompromised patients. For many of these infections, prompt initiation of appropriate antimicrobial therapy may be life saving. Prophylactic use of antibiotics, antifungal drugs, or antiviral agents is indicated in specific groups of immunocompromised patients.
Keywords: *AIDS-Related Opportunistic Infections Human *Immunocompromised Host *Otitis *Respiratory Tract Infections *Sinusitis *Stomatognathic Diseases Support, U.S. Gov't, Non-P.H.S. JOURNAL ARTICLE REVIEW REVIEW, TUTORIALKWDaids-relatedopportunisticinfectionshumanKWDimmunocompromisedhostKWDotitisKWDrespiratorytractinfectionsKWDsinusitisKWDstomatognathicdiseasessupport,uKWDsKWDgov't,non-pKWDhKWDsKWDjournalarticlereviewreview,tutorial
950930
M9590857

Copyright © 1995 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1995. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1995. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .